Quadrant Private Wealth Management’s GSK GSK Stock Holding History

Quadrant Private Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$247K	Buy	4,673 +303	+7%	+$16K	0.06%	142
2026 Q1	$243K	Buy	4,370 +131	+3%	+$7.1K	0.04%	252
2025 Q4	$210K	Buy	+4,239	New	+$198K	0.03%	263
2025 Q2	–	Sell	-5,511	Closed	-$216K	–	254
2025 Q1	$216K	Sell	5,511 -1,572	-22%	-$57.5K	0.05%	215
2024 Q4	$242K	Buy	7,083 +63	+0.9%	+$2.27K	0.06%	211
2024 Q3	$290K	Buy	7,020 +5	+0.1%	+$205	0.07%	190
2024 Q2	$273K	Buy	7,015 +357	+5%	+$15K	0.06%	198
2024 Q1	$288K	Sell	6,658 -937	-12%	-$38.6K	0.07%	184
2023 Q4	$285K	Sell	7,595 -2,917	-28%	-$105K	0.08%	182
2023 Q3	$385K	Sell	10,512 -436	-4%	-$15.5K	0.13%	136
2023 Q2	$394K	Buy	10,948 +64	+0.6%	+$2.3K	0.11%	152
2023 Q1	$391K	Sell	10,884 -10	-0.1%	-$350	0.12%	147
2022 Q4	$386K	Buy	+10,894	New	+$363K	0.13%	141
2022 Q2	$517K	Buy	9,423 +776	+9%	+$42.8K	0.21%	104
2022 Q1	$477K	Buy	8,647 +1,239	+17%	+$67.3K	0.18%	121
2021 Q4	$408K	Sell	7,408 -163	-2%	-$8.48K	0.15%	138
2021 Q3	$362K	Buy	7,571 +542	+8%	+$27.2K	0.15%	140
2021 Q2	$350K	Sell	7,029 -80	-1%	-$3.84K	0.14%	141
2021 Q1	$317K	Hold	7,109	–	–	0.14%	148
2020 Q4	$327K	Sell	7,109 -853	-11%	-$39.2K	0.15%	135
2020 Q3	$375K	Hold	7,962	–	–	0.19%	112
2020 Q2	$406K	Buy	7,962 +780	+11%	+$40K	0.23%	103
2020 Q1	$340K	Buy	+7,182	New	+$383K	0.28%	83

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Quadrant Private Wealth Management's GSK Position: Q2 2026 in Review

Quadrant Private Wealth Management increased its GSK (GSK) stake by 6.9% in Q2 2026, buying an estimated $16K and bringing the position to 4,673 shares worth $247K. The position accounts for 0.06% of the portfolio, ranked #142.

Quadrant Private Wealth Management first reported a position in GSK in Q1 2020 and has held it in 23 quarters since. The position peaked at $517K in Q2 2022. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Quadrant Private Wealth Management held 4,673 shares of GSK worth $247K as of Q2 2026.
Quadrant Private Wealth Management bought 303 GSK shares in Q2 2026, an estimated $16K.
GSK made up 0.06% of Quadrant Private Wealth Management's portfolio in Q2 2026, its #142 holding.
Quadrant Private Wealth Management first reported a position in GSK in Q1 2020 and has held it in 23 quarters since.
Quadrant Private Wealth Management's GSK position peaked at $517K in Q2 2022.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Quadrant Private Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.